杂志简称：immunotherapy、uk
中文译名：《免疫疗法》
收录属性：scie（2024版）, 目次收录（维普）,英文期刊,
自引率：3.40%
投稿方向：医学、immunology 免疫学
SCI/E期刊基本信息
出版周期：年18期 地区：英国
中科院分区：4区
是否TOP：非TOP期刊
是否综述：非综述期刊
是否OA：非OA期刊
国际标准刊号：ISSN1750-743X；EISSN1750-7448
杂志语言：英语
出版国家：英国
杂志官网 联系方式
出版地址：FUTURE MEDICINE LTD,UNITEC HOUSE,3RD FLOOR,2 ALBERT PLACE,FINCHLEY CENTRAL,LONDON,ENGLAND,N3 1QB
杂志邮箱：
投稿网址：https://mc04.manuscriptcentral.com/fm-imt
杂志官方网址：https://www.futuremedicine.com/loi/imt
出版商网址：http://www.futuremedicine.com
杂志投稿要求
期刊信息【杂志社官方网站信息】
Immunotherapy
Aims & Scope
The field of immunotherapy is moving forward at an unprecedented rate, and a range of therapeutic approaches are now used in clinical practice, often with outstanding success. Cancer immunotherapies are coming of age and have the potential to produce long-lasting remission, often with fewer side effects and reduced drug resistance compared with conventional therapies. Recently the FDA has approved immunotherapies for melanoma and lung cancer, and clinical trials are yielding positive results for a range of cancer types, reflecting the promising new role for immunotherapy in cancer treatment. Immunotherapies are also being applied in a variety of other disease areas, including allergy, rheumatoid disease, autoimmunity and transplantation, as well as in many infections, such as HIV and hepatitis.
Many aspects of the immune system and mechanisms of immunomodulatory therapies remain to be elucidated in order to exploit fully the emerging opportunities. Those involved in the research and clinical applications of immunotherapy are challenged by the huge and intricate volumes of knowledge arising from this fast-evolving field. The journal Immunotherapy offers the scientific community an interdisciplinary forum, providing them with information on the most recent advances of various aspects of immunotherapies, in a concise format to aid navigation of this complex field.
Articles published in Immunotherapy include key areas such as:
Cancer immunotherapy, including checkpoint blockade, cancer vaccines, adoptive T cell therapy, monoclonal antibodies and cytokines
Combined chemo/radio immunotherapy in cancer treatment
Biomarkers for personalized cancer immunotherapy
Allergen immunotherapy, including sublingual, subcutaneous and oral immunotherapy
Restorative immunotherapy for HIV and other immunocompromised patients
Suppressive immunotherapy for autoimmunity diseases and transplantation
Basic science of immunotherapeutic approaches
Drug–immune system interactions
Drug delivery systems, drug combinations and drug–drug interactions
Summaries evaluating newly approved immunotherapeutic agents
Newly identified immune targets of drugs
Results of recent findings and clinical trials relevant to the field of immunotherapy
Post marketing research, including adverse events, drug safety, pharmacoeconomics, cost–benefit issues, real-world evidence and outcomes research
Immunotherapy delivers essential information in concise, at-a-glance article formats. Key advances in the field are reported and analyzed by international experts, providing an authoritative but accessible forum for this vitally important area of research. Unsolicited article proposals are welcomed and authors are required to comply fully with the journal's Disclosure & Conflict of Interest Policy as well as major publishing guidelines, including ICMJE and GPP3.